Clinical trial

Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's Dementia

NCT03441516

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2018-04-19

PhasePHASE4

Study timeline

Study start (actual)2018-04-19Date precision: day

Registry last updated2020-12-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer's Diseaseunresolved

Interventions

Alfoatirin® Tab. + Aripezil® Tab.DRUG

Aripezil® Tab.DRUG

Sponsors & collaborators

Yuhan Corporationlead sponsor

Mapped research locations

BusanSouth Korea6

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03441516 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.